Pfizer, BioNTech say COVID booster highly effective

Pfizer and German partner BioNTech on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the virus, including the Delta variant. Conway G. Gittens reports.